Cas:122894-56-8 N,N-dimethyl-1-morpholin-2-ylmethanamine manufacturer & supplier

Chemical Name:N,N-dimethyl-1-morpholin-2-ylmethanamine

CAS.NO:122894-56-8

Synonyms:2-Morpholinemethanamine, N,N-dimethyl-;N,N-Dimethyl-1-(2-morpholinyl)methanamine;N,N-Dimethyl-2-morpholinmethanamine;N,N-Dimethyl-1-(morpholin-2-yl)methanamine;Dimethyl-morpholin-2-ylmethylamine;N,N-Dimethyl-2-morpholinemethanamine;N,N-dimethyl-1-morpholin-2-yl-methanamine

Molecular Formula:C₇H₁₆N₂O

Molecular Weight:144.215

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:198.8±15.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.443

PSA:24.50000

Exact Mass:144.126266

LogP:-1.04

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Morpholinemethanamine, N,N-dimethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N-dimethyl-1-morpholin-2-yl-methanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dimethyl-morpholin-2-ylmethylamine Use and application,N,N-Dimethyl-2-morpholinemethanamine technical grade,usp/ep/jp grade.

Related News: The South Korean government is banning entry to all foreign nationals who visited China’s Hubei province in the past 14 days. N,N-dimethyl-1-morpholin-2-ylmethanamine manufacturer What is the difference? Raw material refers to chemical compounds that are used as a base to make an API. N,N-dimethyl-1-morpholin-2-ylmethanamine supplier British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. N,N-dimethyl-1-morpholin-2-ylmethanamine vendor China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. N,N-dimethyl-1-morpholin-2-ylmethanamine factory The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.